Furthermore, ASGPR1+ EVs were also found to correlate with the hepatic vein portal gradient (HVPG), being a potential non-invasive biomarker of portal hypertension in patients with NASH and cirrhosis. The gene discussed is ASGR1; the disease is Cirrhosis.